HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Characterization of a diagnostic Fab fragment binding trimeric Lewis X.

Abstract
Lewis X trisaccharides normally function as essential cell-cell interaction mediators. However, oligomers of Lewis X trisaccharides expressed by the parasite Schistosoma mansoni seem to be related to its evasion of the immune response of its human host. Here we show that monoclonal antibody 54-5C10-A, which is used to diagnose schistosomiasis in humans, interacts with oligomers of at least three Lewis X trisaccharides, but not with monomeric Lewis X. We describe the sequence and the 2.5 A crystal structure of its Fab fragment and infer a possible mode of binding of the polymeric Lewis X from docking studies. Our studies indicate a radically different mode of binding compared to Fab 291-2G3-A, which is specific for monomeric Lewis X, thus providing a structural explanation of the diagnostic success of 54-5C10-A.
AuthorsDaniël C de Geus, Anne-Marie M van Roon, Ellen A J Thomassen, Cornelis H Hokke, André M Deelder, Jan Pieter Abrahams
JournalProteins (Proteins) Vol. 76 Issue 2 Pg. 439-47 (Aug 01 2009) ISSN: 1097-0134 [Electronic] United States
PMID19173313 (Publication Type: Journal Article)
Copyright2008 Wiley-Liss, Inc.
Chemical References
  • Antibodies, Monoclonal
  • Immunoglobulin Fab Fragments
  • Lewis X Antigen
  • Trisaccharides
  • galactosyl-(1,4)-fucopyranosyl-(1,3)-N-acetylglucosamine
Topics
  • Amino Acid Sequence
  • Animals
  • Antibodies, Monoclonal (chemistry, immunology)
  • Binding Sites
  • Crystallography, X-Ray
  • Humans
  • Immunoglobulin Fab Fragments (chemistry, immunology)
  • Lewis X Antigen (analogs & derivatives)
  • Mice
  • Models, Molecular
  • Molecular Sequence Data
  • Protein Conformation
  • Sequence Alignment
  • Surface Plasmon Resonance
  • Trisaccharides (chemistry, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: